Rising Demand For Minimally Invasive Procedures Drives Growth In The Tumor Ablation Market: A Key Factor Shaping the Future of the Tumor Ablation Market in 2025

What Are the Projections for the Size and Growth Rate of the Tumor Ablation Market?
In recent times, there has been a swift expansion in the size of the tumor ablation market. Projected to surge from $1.45 billion in 2024 to $1.62 billion in 2025, it reflects a compound annual growth rate (CAGR) of 12.1%. The growth witnessed during the past period can be credited to enhancements in ablation procedures' precision and efficiency, an upward trend in healthcare expenditure in budding economies, a demographic lean towards the elderly, an escalated burden of cancer, and a worldwide increase in the occurrence of cancer.

The size of the tumor ablation market is predicted to experience accelerated expansion in the forthcoming years. The market is projected to rise to a value of $2.54 billion by 2029, maintaining a compound annual growth rate (CAGR) of 11.8%. The anticipated growth in this period can be linked to factors such as escalating cancer rates, the increasing popularity of minimally invasive procedures, expanding applications, greater cost-effectiveness in healthcare, and heightened awareness and education. Dominant trends expected during the forecast period entail technological advancements, ongoing evolution of superior ablation technologies, the incorporation of artificial intelligence, emphasis on outpatient environments, and strategies that put the patient first.

What Are the Main Catalysts for Growth in the Tumor Ablation Market?
The tumor ablation market is projected to expand, driven by the rising popularity of minimally invasive procedures. These procedures, which include medical or surgical interventions requiring little to no incisions, are increasingly preferred due to their shorter recovery times, reduced risk of complications, and less post-operative discomfort than traditional surgeries. Tumor ablation, a key component in these minimally invasive procedures, employs methods such as radiofrequency, microwave, or cryoablation to obliterate cancer tissues, causing the least damage to the nearby healthy tissue and leading to quicker recovery periods. As an example, in January 2024, Intuitive Surgical Inc., a U.S. company known for producing robotic products, reported the placement of 415 da Vinci surgical systems, which are robotic surgical systems designed for minimally invasive surgery, in the last quarter of 2023. This was a 12% rise compared to 2022, demonstrating the increased utilization of minimally invasive procedures and ultimately boosting the growth of the tumor ablation market.

Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=17283&type=smp

Which Businesses Are at the Forefront of Tumor Ablation Market Development?
Major companies operating in the tumor ablation market are Abbott Laboratories, Medtronic plc, Siemens Healthineers AG, Stryker Corporation, Boston Scientific Corporation, Olympus Corporation, Terumo Corporation, Varian Medical Systems Inc., Merit Medical Systems Inc., Bioventus LLC, Accuray Incorporated, AtriCure Inc., AngioDynamics Inc., EDAP TMS S.A., NeuWave Medical Inc., Mirabilis Medical Inc., STARMed Co. Ltd., Profound Medical Corp., RF Medical Co. Ltd., IceCure Medical Ltd., MedWaves Inc., Chongqing Haifu Medical Technology Co. Ltd.

What Are the Latest Innovations in the Tumor Ablation Market?
Leading entities in the tumor ablation market are focusing on the creation of groundbreaking products such as bone tumor ablation instruments to boost the effectiveness of treatments, enhance patient experience, and increase the spectrum of tumors to be treated. A bone tumor ablation system is a specific medical device employed for administering treatments for bone tumors via minimally invasive procedures. In an example from March 2024, Medtronic plc - a medical apparatus firm based in Ireland - received clearance from the U.S. Food and Drug Administration (FDA) for its novel OsteoCool 2.bone tumor ablation system. This advanced apparatus is engineered to address painful bone metastases and benign bone tumors like osteoi osteoma. The OsteoCool 2.0 system permits the concurrent usage of four internally-cooled probes, giving physicians the capacity to treat two vertebral bodies simultaneously or construct larger ablation areas in extra-spinal applications. It produces 20W for each channel, offering over double the power of the bone tumor ablation instrument from Stryker, namely OptaBlate.

How Is the Tumor Ablation Market Segmented?
The tumor ablation market covered in this report is segmented -

1) By Type: Thermal Ablation, Chemical Ablation
2) By Types Of Treatment: Percutaneous, Laparoscopic, Surgical
3) By Application: Kidney Cancer, Liver Cancer, Breast Cancer, Lung Cancer, Prostate Cancer, Other Cancer
4) By End Users: Hospitals, Oncology Centers, Other End Users

Subsegments:
1) By Thermal Ablation: Radiofrequency Ablation (RFA), Microwave Ablation (MWA), Cryoablation, Laser Ablation, High-Intensity Focused Ultrasound (HIFU)
2) By Chemical Ablation: Ethanol Ablation, Acetic Acid Ablation, Chemotherapy-Based Ablation (Chemoembolization)

Pre-Book Your Report Now For A Swift Delivery:
https://www.thebusinessresearchcompany.com/report/tumor-ablation-global-market-report

Where Is the Tumor Ablation Market Growth Most Prominent?
North America was the largest region in the tumor ablation market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the tumor ablation market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

What Is Covered In The Tumor Ablation Global Market Report?

- Market Size Analysis: Analyze the Tumor Ablation Market size by key regions, countries, product types, and applications.
- Market Segmentation Analysis: Identify various subsegments within the Tumor Ablation Market for effective categorization.
- Key Player Focus: Focus on key players to define their market value, share, and competitive landscape.
- Growth Trends Analysis: Examine individual growth trends and prospects in the Market.
- Market Contribution: Evaluate contributions of different segments to the overall Tumor Ablation Market growth.
- Growth Drivers: Detail key factors influencing market growth, including opportunities and drivers.
- Industry Challenges: Analyze challenges and risks affecting the Tumor Ablation Market.
- Competitive Developments: Analyze competitive developments, such as expansions, agreements, and new product launches in the market.

Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=17283

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.